1. Home
  2. ENTA vs IH Comparison

ENTA vs IH Comparison

Compare ENTA & IH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENTA
  • IH
  • Stock Information
  • Founded
  • ENTA 1995
  • IH 1996
  • Country
  • ENTA United States
  • IH China
  • Employees
  • ENTA N/A
  • IH N/A
  • Industry
  • ENTA Biotechnology: Pharmaceutical Preparations
  • IH Other Consumer Services
  • Sector
  • ENTA Health Care
  • IH Real Estate
  • Exchange
  • ENTA Nasdaq
  • IH Nasdaq
  • Market Cap
  • ENTA 109.0M
  • IH 88.8M
  • IPO Year
  • ENTA 2013
  • IH 2020
  • Fundamental
  • Price
  • ENTA $5.09
  • IH $1.70
  • Analyst Decision
  • ENTA Buy
  • IH
  • Analyst Count
  • ENTA 4
  • IH 0
  • Target Price
  • ENTA $17.25
  • IH N/A
  • AVG Volume (30 Days)
  • ENTA 503.4K
  • IH 11.6K
  • Earning Date
  • ENTA 02-18-2025
  • IH 02-27-2025
  • Dividend Yield
  • ENTA N/A
  • IH 4.94%
  • EPS Growth
  • ENTA N/A
  • IH N/A
  • EPS
  • ENTA N/A
  • IH 0.28
  • Revenue
  • ENTA $67,635,000.00
  • IH $134,002,994.00
  • Revenue This Year
  • ENTA $8.11
  • IH $15.90
  • Revenue Next Year
  • ENTA N/A
  • IH $8.64
  • P/E Ratio
  • ENTA N/A
  • IH $6.08
  • Revenue Growth
  • ENTA N/A
  • IH N/A
  • 52 Week Low
  • ENTA $4.71
  • IH $1.47
  • 52 Week High
  • ENTA $17.80
  • IH $2.48
  • Technical
  • Relative Strength Index (RSI)
  • ENTA 38.07
  • IH 52.33
  • Support Level
  • ENTA $4.94
  • IH $1.60
  • Resistance Level
  • ENTA $5.31
  • IH $1.70
  • Average True Range (ATR)
  • ENTA 0.32
  • IH 0.09
  • MACD
  • ENTA 0.11
  • IH 0.01
  • Stochastic Oscillator
  • ENTA 39.05
  • IH 63.12

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.

About IH iHuman Inc.

iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources. The majority of iHuman Inc's revenue comes from mainland China.

Share on Social Networks: